UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE
14F-1/A
(Amendment No. 1)
Under the Securities Exchange Act of 1934
PURERAY CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Washington
|
|
000-32089
|
|
91-2023071
|
(State or Other Jurisdiction
|
|
(Commission File Number)
|
|
(I.R.S. Employer
|
of Incorporation)
|
|
|
|
Identification No.)
|
|
|
|
3490 Piedmont Road, Suite 1120
|
|
|
Atlanta, GA
|
|
30305
|
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
(404) 869-6242
Registrants Telephone Number, Including International Code and Area Code
North American Natural Gas, Inc.
(Former name or former address, if changed since last report)
* * * * * * * * * * * * *
NO VOTE OR OTHER ACTION OF THE COMPANYS STOCKHOLDERS
IS REQUIRED IN CONNECTION WITH THIS INFORMATION STATEMENT.
NO PROXIES ARE BEING SOLICITED AND YOU ARE NOT
REQUESTED TO SEND THE COMPANY A PROXY.
* * * * * * * * * * * * *
INFORMATION STATEMENT PURSUANT TO SECTION 14(f) OF THE SECURITIES
EXCHANGE ACT OF 1934 AND SEC RULE 14f-1
NOTICE OF CHANGE IN MAJORITY OF DIRECTORS
July 31, 2008
This Information Statement
is being furnished to holders of record as of July 30, 2008 of the
common stock par value $0.0001 per share (Common Stock), and preferred stock, par value $0.0001
per share (the Special Voting Stock), of PureRay Corporation, a Washington corporation (the
Company), in accordance with the requirements of Section 14(f) of the Securities Exchange Act of
1934, as amended (the 34 Act), and Rule 14f-1 promulgated thereunder.
No vote or other action by our stockholders is requested or required in response to this
Information Statement. Proxies are not being solicited. References throughout this Information
Statement to we, us and our are to the Company.
This Amendment No. 1 on Schedule 14F-1/A (this First Amendment) amends the Schedule 14F-1
originally filed by PureRay Corporation, a Washington corporation (formerly North American Natural
Gas, Inc.) (the Company), with the Securities and Exchange Commission on July 31, 2008 (the
Original Schedule 14F-1) to make certain corrections regarding the compensation of the Companys
directors and executive officers and certain related party transactions on pages 9 and 10 of the
Original Schedule 14F-1. This First Amendment does not amend or modify any other information set
forth in the Original Schedule 14F-1, which has been restated in its entirety in this First Amendment.
INTRODUCTION
As previously reported in the Companys Current Report on Form 8-K filed with the Securities and
Exchange Commission on July 31, 2008 (the PureRay Acquisition Form 8-K), on July 24, 2008, the
Company, PureRay Acquisition Inc., a corporation formed under the laws of Canada (PureRay
Acquisition Inc.) and a wholly-owned subsidiary of PureRay Holdings ULC, an unlimited liability
corporation formed under the laws of the Province of Alberta and a wholly-owned subsidiary of the
Company (PureRay Holdings), PureRay Corporation, a corporation formed under the laws of Canada
(PureRay), and Mickael Joasil, Derek Blackburn, F.W.F Robinson, Frank ODea, Kairos Partners, LLC
(Kairos), Thomas J. Broeski, Raj Kurichh, Megs Padiachy, Ramlia Padiachy, Patrick Pierre and
Matthew Sicoli (together, the PureRay Shareholders), entered into a Share Purchase Agreement
(the Share Purchase Agreement), whereby PureRay Acquisition acquired (the Acquisition) all of
the outstanding shares of PureRay (the PureRay Shares) from the PureRay Shareholders. The
Acquisition was completed on July 24, 2008.
Pursuant to the terms of the Share Purchase Agreement, PureRay Acquisition acquired the PureRay
Shares for an amount equal to US$35,855,000
,
which the parties agreed to be the fair market value
of the PureRay Shares. The purchase price was paid by the issuance of one exchangeable share,
without par value, of PureRay Acquisition (each, an Exchangeable Share) for each PureRay Share
acquired, for a total of 35,855,000 Exchangeable Shares. For information about the Exchangeable
Shares, see Item 1.01 of the PureRay Acquisition Form 8-K, which information is incorporated herein
by reference.
In connection with the Share Purchase Agreement, on July 24, 2008, the Company, PureRay Holdings,
PureRay Acquisition and Derek Blackburn, as trustee (the Trustee), entered into a Voting and
Exchange Trust Agreement (the Exchange Agreement). Pursuant to the Exchange Agreement, the
Company issued shares of preferred stock of the Company, par value $0.0001 per share (the Special
Voting Stock), in a ratio of a quarter (1/4) share of Special Voting Stock for each Exchangeable
Share issued in connection with the Acquisition (for a total of 8,963,750 shares of Special Voting
Stock) to the Trustee to be held for and on behalf of the registered holders of the Exchangeable
Shares. The Special Voting Stock was issued in connection with the Acquisition to provide holders
of the Exchangeable Shares with the right to vote at meetings of the shareholders of the Company or
in connection with a consent of the shareholders of the Company.
Each share of Special Voting Stock issued entitles the holder of record to four votes, equal to
four shares of the Companys Common Stock, and each quarter (1/4) share of Special Voting Stock
entitles the holder of record to one vote, equal to one share of the Companys Common Stock, at a
meeting or in connection with a consent of the shareholders of the Company (the Voting Rights).
Each holder of Exchangeable Shares is entitled to instruct the Trustee to cast and exercise one of
the votes comprising the Voting Rights for each Exchangeable Share held as of the applicable record
date. To the extent that no instructions are received from a holder of Exchangeable Shares, the
Trustee may not exercise the Voting Rights with respect to such Exchangeable Shares. For
information about the Exchange Agreement and Special Voting Stock, see Item 1.01 of the PureRay
Acquisition Form 8-K, which information is incorporated herein by reference.
In connection with the Acquisition, Derek Blackburn, Mickael Joasil, Frank ODea and Jefrey M.
Wallace were appointed to the Companys Board of Directors (the Board), effective upon the
expiration of the 10-day period beginning on the date of the filing of this Information Statement
with the Securities and Exchange Commission pursuant to Rule 14f-1 of the 34 Act and the mailing of
this Information Statement to the Companys stockholders (the Effective Date). Also effective
upon the Effective Date, Jim Glavas, the Companys current sole director, will resign and the
composition of the Companys Board will change such that Messrs. ODea, Wallace, Joasil and
Blackburn will be the Companys directors.
Effective upon the completion of the Acquisition, Mr. Glavas resigned as the President, Chief
Executive Officer, Chief Financial Officer, Secretary, Treasurer and Principal Accounting Officer
of the Company. Prior to his resignation, Mr. Glavas appointed Jefrey M. Wallace as the Companys
new Chief Executive Officer, President and Secretary and Derek Blackburn as the Companys new Chief
Financial Officer and Treasurer.
Please read this Information Statement carefully. It contains certain biographical and other
information concerning the executive officers and directors that will be in place on the Effective
Date. You are not, however, being asked to or required to take any action in connection with this
Information Statement.
VOTING SECURITIES AND PRINCIPAL HOLDERS THEREOF
The Company is presently authorized to issue 100,000,000 shares of Common Stock, and 20,000,000
shares of preferred stock, par value $0.0001 per share, of which 10,000,000 shares have been
classified as Special Voting Stock. There are currently issued and outstanding 15,500,000 shares of
Common Stock and 8,963,750 shares of Special Voting Stock. In addition, the Company has warrants
outstanding exercisable for an additional 2,000,000 shares of Common Stock. Each share of Common
Stock is entitled to one vote. Each share of Special Voting Stock issued entitles the holder of
record to four votes, equal to four shares of the Companys Common Stock, and each quarter (1/4)
share of Special Voting Stock entitles the holder of record to one vote, equal to one share of the
Companys Common Stock. Each holder of Exchangeable Shares is entitled to instruct the Trustee to
cast and exercise one of the votes comprising the Voting Rights for each Exchangeable Share held as
of the applicable record date.
The following table sets forth certain information with respect to the beneficial ownership of our
voting securities following the completion of the Acquisition and related private placement (the
Private Placement) described in Items 1.01 and 3.02 of the PureRay Acquisition Form 8-K by (i)
any person or group owning more than 5% of each class of voting securities, (ii) each director,
(iii) our former chief executive officer and our top two most highly compensated executive officers
other than our former chief executive officer who we refer to as our named executive officers and
(iv) all named executive officers and directors as a group, as of July 28, 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name and Address of
|
|
Amount and Nature of Beneficial Ownership (1)
|
Beneficial Owner
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Owner of More than
|
|
Common
|
|
Special Voting Stock
|
|
Warrants
|
|
|
|
|
|
Percentage of
|
5% of Class
|
|
Stock
|
|
(2)
|
|
(3)
|
|
Total
|
|
Common (%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Kairos Partners, LLC
3625 Cumberland
Blvd.,
Suite 600,
Atlanta, GA, 30339
|
|
|
5,355,000
|
(4)(5)(6)
|
|
|
1,338,750
|
(4)(5)
|
|
|
0
|
|
|
|
6,693,750
|
(4)(5)(6)(8)
|
|
|
25.68%
|
(4)(5)(6)(8)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PureRay Corporation
3490 Piedmont Road,
Suite 1120,
Atlanta, GA, 30305 (8)
|
|
|
4,355,000
|
(4)(5)(6)
|
|
|
1,088,750
|
(4)(5)
|
|
|
0
|
|
|
|
5,443,750
|
(4)(5)(6)(8)
|
|
|
21.93%
|
(4)(5)(6)(8)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F.W.F Robinson
5851 Knights Drive
Manitock, ON
K4M 1K3
|
|
|
3,000,000
|
(6)
|
|
|
750,000
|
(6)
|
|
|
0
|
|
|
|
3,750,000
|
(6)
|
|
|
16.22
|
%(6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
511919 NB Inc.
595 Burrard Street,
Suite
3123,Vancouver, BC, V7X 1J1
|
|
|
1,500,000
|
|
|
|
0
|
|
|
|
1,500,000
|
|
|
|
3,000,000
|
|
|
|
17.65
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Directors and
Executive Officers
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derek Blackburn
(director nominee,
Chief Financial
Officer and
Treasurer)(7)
|
|
|
12,835,000
|
(6)
|
|
|
3,208,750
|
|
|
|
0
|
|
|
|
16,043,750
|
(6)
|
|
|
45.30
|
%(6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Jim Glavas
(director and
former President,
Chief Executive
Officer, Chief
Financial Officer,
Secretary,
Treasurer and
Principal
Accounting Officer)
(7)
|
|
|
300,000
|
|
|
|
0
|
|
|
|
0
|
|
|
|
300,000
|
|
|
|
1.93
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mickael Joasil
(director nominee)
(7)
|
|
|
12,835,000
|
(6)
|
|
|
3,208,750
|
(6)
|
|
|
0
|
|
|
|
16,043,750
|
(6)
|
|
|
45.30
|
%(6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Frank ODea
(director nominee)
(7)
|
|
|
1,000,000
|
(6)
|
|
|
250,000
|
|
|
|
0
|
|
|
|
1,250,000
|
(6)
|
|
|
6.06
|
%(6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Jefrey M. Wallace
(director nominee
and current
Chief
Executive Officer,
President
and
Secretary)(7)
|
|
|
5,355,000
|
(4)(5)(6)
|
|
|
1,338,750
|
(4)(5)(6)
|
|
|
0
|
|
|
|
6,693,750
|
(4)(5)(6)(8)
|
|
|
25.68%
|
(4)(5)(6)(8)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All Directors and
Executive Officers
(5 persons)
|
|
|
32,325,000
|
(6)
|
|
|
8,006,250
|
|
|
|
0
|
|
|
|
40,0331,250
|
(6)
|
|
|
68.02
|
%(6)
|
|
|
|
(1)
|
|
In determining beneficial ownership of our Common Stock as of a given date, the number of
shares shown includes shares of Common Stock which may be acquired on exercise of warrants within
60 days of that date as well as shares of Common Stock which may be acquired pursuant to the
exchange of the Exchangeable Shares. In determining the percent of Common Stock owned by a person
or entity on July 28, 2008, (a) the numerator is the number of shares of the class beneficially
owned by such person or entity, including shares of Common Stock which may be acquired on exercise
of warrants within 60 days of that date as well as shares of Common Stock which may be acquired
pursuant to the exchange of the Exchangeable Shares, and (b) the denominator is the sum of (i) the
total shares of Common Stock outstanding on July 28, 2008, and (ii) the total number of shares that
the beneficial owner may acquire on exercise of warrants within 60 days of that date as well as
pursuant to the exchange of the Exchangeable Shares. The Special Voting Stock was issued to provide
holders of the Exchangeable Shares (which have no right to vote with our Common Stock) the right to
one vote per share of our Common Stock into which such holders Exchangeable Shares may be
exchanged, and as such the Special Voting Stock is not included in the determination of the percent
of Common Stock owned by such holder. As of July 28, 2008, 15,500,000 shares of our Common Stock
and 8,963,750 shares of Special Voting Stock were issued and outstanding. Unless otherwise stated,
each beneficial owner has sole power to vote and dispose of its shares. For information about the
Exchangeable Shares and Special Voting Stock, please see Item 1.01 of the PureRay Acquisition Form
8-K, which is incorporated herein by reference.
|
|
(2)
|
|
8,963,750 shares of our Special Voting Stock were issued on July 24, 2008, pursuant to the
Share Purchase Agreement and the Exchange Agreement.
|
|
(3)
|
|
One warrant was issued for each share of our Common Stock subscribed for in connection with the
Private Placement, with a total of 2,000,000 warrants issued.
|
|
(4)
|
|
Jefrey M. Wallace, a director nominee and our Chief Executive Officer, President and Secretary,
may be deemed to have beneficial ownership of the Exchangeable Shares, Special Voting Stock and
shares of our Common Stock beneficially owned by Kairos pursuant to his 28% membership interest in
Kairos. Mr. Wallace is also a managing member of Kairos.
|
|
(5)
|
|
Pursuant to an Escrow and Share Purchase Agreement dated July 24, 2008 (the Escrow Agreement)
entered into between Kairos, PureRay Acquisition and Wildeboer Dellelce LLP in connection with the
Acquisition, 4,355,000 of the Exchangeable Shares held by Kairos have been placed into escrow and
will be incrementally released upon the occurrence of certain performance-based milestone events
with respect to PureRay. Kairos has appointed the secretary of PureRay Acquisition to exercise the
limited voting rights attaching to the Exchangeable Shares and Voting Rights of the Special Voting
Stock issued with respect to the Exchangeable Shares held in escrow until such shares are released
to Kairos. Kairos has no right to dividends or other distributions or payments made on the
Exchangeable Shares held in escrow until such shares are released to Kairos. For information about
the Escrow Agreement, Exchangeable Shares and Special Voting Stock, please see Item 1.01 of the
PureRay Acquisition Form 8-K, which is incorporated herein by reference.
|
|
(6)
|
|
Shares of Common Stock beneficially owned reflect the number of shares of Common Stock for
which the holders Exchangeable Shares may be exchanged.
|
|
(7)
|
|
The address of each of our directors and executive officers is 3490 Piedmont Road, Suite 1120,
Atlanta, GA, 30305.
|
|
(8)
|
|
In connection with the Acquisition, on July 24, 2008, PureRay Acquisition amalgamated with PureRay and is now PureRay Corporation, a corporation formed under the laws of Canada.
|
DIRECTORS AND EXECUTIVE OFFICERS
The following table sets forth the name, age and position of each of our directors and executive
officers:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date First Elected or
|
Name
|
|
Age
|
|
Positions
|
|
Appointed
|
|
|
|
|
|
|
|
|
|
|
Derek Blackburn
|
|
|
30
|
|
|
Director nominee, Chief Financial
Officer and Treasurer
|
|
July 24, 2008
|
Jim Glavas
|
|
|
44
|
|
|
Director
|
|
May 22, 2003
|
Mickael Joasil
|
|
|
23
|
|
|
Director nominee
|
|
July 24, 2008
|
Frank ODea
|
|
|
63
|
|
|
Director nominee
|
|
July 24, 2008
|
Jefrey M. Wallace
|
|
|
36
|
|
|
Director and Chief Executive Officer
|
|
July 24, 2008
|
Our board of directors is currently composed of one member, Jim Glavas. In connection with the
Acquisition, on July 24, 2008, Mr. Glavas submitted his resignation from the board of directors.
Also in connection with the Acquisition, on July 24, 2008, prior to his resignation, Jim Glavas
appointed Derek Blackburn, Mickael Joasil, Frank O Dea and Jefrey M. Wallace as director nominees.
The resignation of Mr. Glavas as a director and the appointment of our director nominees are
effective on the 10th day after the mailing of an information statement to our stockholders that
complies with the requirements of Rule 14f-1 promulgated under the Exchange Act, after which our
board of directors will be composed of Mr. Blackburn, Mr. Joasil, Mr. ODea and Mr. Wallace. The
director nominees will serve until the close of our 2008 annual meeting of shareholders or the
earlier of their respective resignations or until their respective successors are elected or
appointed and qualified. None of the foregoing directors are independent directors, as the term
independent is defined by the rules of the Nasdaq Stock Market.
In connection with the Acquisition, on July 24, 2008, Mr. Glavas resigned as our President, Chief
Executive Officer, Chief Financial Officer, Secretary, Treasurer and Principal Accounting Officer.
Prior to his resignation, Mr. Glavas appointed Mr. Wallace as our new Chief Executive Officer,
President and Secretary and Mr. Blackburn as our new Chief Financial Officer and Treasurer, in each
case effective immediately.
BIOGRAPHICAL INFORMATION REGARDING
THE DIRECTORS AND EXECUTIVE OFFICERS
The principal occupation and brief summary of the background of the Companys directors and
executive officers is as follows:
Jim Glavas
graduated from the Financial Management program at the British Columbia Institute of
Technology in Vancouver, Canada in 1984. From there, he spent several years in the banking industry
as a leasing administrator with First City Trust. In 1990 he changed career direction to
become the General Sales Manager for Western Canada for Contour Distributors, a leading supplier
and distributor of top-of-the-line appliances and high-end solid surface products.
In April 1996, Mr. Glavas purchased the exclusive Avonite solid surface countertops distribution
rights for Western Canada and formed DG Pacific Distribution Ltd. In January 2001, DG Pacific
Distribution Ltd. acquired the national distribution rights for two prominent product lines in the
countertop industry. Mr. Glavas sold DG Pacific Distribution Ltd. in December 2002 and currently
works as an independent consultant in development and market penetration for the counter top
industry.
Derek Blackburn
will serve as our Chief Financial Officer and Treasurer effective immediately and a
director effective on the 10th day after the mailing of an information statement to our
stockholders that complies with the requirements of Rule 14f-1 promulgated under the Exchange Act.
In 2002, he founded and has served as President since such date of Crystal Clear Window Works, a
Window Restoration service company. Mr. Blackburn was responsible for funding the start-up and
building a network of dealers across Canada. In 2004, Mr. Blackburn partnered with Mr. Joasil to
co-found and build Window Medics International (Window Medics). Window Medics commercialized a
patent pending moisture control and damage prevention system that restores clarity and insulation
to failed insulated glass unit windows. The Window Medics process provides a cost effective and
environmentally responsible alternative to window replacements. Since December 2004, Mr. Blackburn
has served as Window Medics Chief Operations Officer.
Mickael Joasil
will serve as a director effective on the 10th day after the mailing of an
information statement to our stockholders that complies with the requirements of Rule 14f-1
promulgated under the Exchange Act. In 2004, Mr. Joasil partnered with Mr. Blackburn to co-found
and build Window Medics International, where Mr. Joasil invented intellectual property used by the
Window Medics International dealer network across North America and in the United Kingdom. Window
Medics International commercialized a patent pending moisture control and damage prevention system
that restores clarity and insulation to failed insulated glass unit windows. The Window Medics
process provides a cost effective and environmentally responsible alternative to window
replacements. Since December 2004, Mr. Joasil has served as Window Medics Chief Executive Officer.
Frank ODea
will serve as a director of the Company effective on the 10th day after the mailing of
an information statement to our stockholders that complies with the requirements of Rule 14f-1
promulgated under the Exchange Act. Since March 2006, Mr. ODea has served as the CEO of Arxx Walls
& Foundations, the largest manufacturer and installer of Insulated Concrete Forms in North America.
Mr. ODea also serves as Chairman of the Board of Directors of Horatio Management, a Toronto based
venture capital firm, as a director of Mount Pleasant Group of Cemeteries, a cemetery and funeral
company, and Chairman of the Board of Directors of Royal Roads University Foundation, a degree
granting institution with a focus on business graduate degrees. Mr. ODea has also founded a number
of not-for-profit organizations including Street Kids International, Canadian Foundation for Aids
Research, War Child Canada, and the Canadian Landmine Foundation. Mr. ODea was recently granted
Canadas highest civilian honor by the Governor General of Canada: Officer of the Order Of Canada.
Jefrey Wallace
will serve as our Chief Executive Officer, President and Secretary effective
immediately and a director effective on the 10th day after the mailing of an information statement
to our stockholders that complies with the requirements of Rule 14f-1 promulgated under the
Exchange Act. Mr. Wallace is a founding managing partner of The Kairos Companies (2006), a
boutique financial services company that advises both institutional and individual clients with
regard to multiple investment and asset class strategies. Specifically, Mr. Wallace has led the
Corporate Finance and Advisory practice assisting entrepreneurs strategize and fund the growth of
their businesses. From 1998 2006, Mr. Wallace was on the initial team of four people who launched
Knowlagent, a human performance enterprise software company that distributes its products
worldwide. Mr. Wallace was primarily responsible for the sales growth of Knowlagent. Mr. Wallace
has a Masters Degree in Management from Georgia State University and a Bachelors Degree in
Management from the Georgia Institute of Technology.
To our knowledge, no director, officer or affiliate of the Company, any owner of record or
beneficially of more than five percent of any class of voting securities of the Company, or any
associate of any such director, officer, affiliate of the Company, or security holder is a party
adverse to the Company or any of its subsidiaries or has a material interest adverse to the Company
or any of its subsidiaries.
To our knowledge, during the past five years, none our officers and directors: (1) have filed a
petition under the federal bankruptcy laws or any state insolvency law, nor had a receiver, fiscal
agent or similar officer appointed by a court for the business or property of such a person, or any
partnership in which he was a general partner at or within two years before the time of such
filing, or any corporation or business association of which he was an executive officer within two
years before the time of such filing; (2) were convicted in a criminal proceeding or named subject
of a pending criminal proceeding (excluding traffic violations and other minor offenses); (3) were
the subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of
any court of competent jurisdiction, permanently or temporarily enjoining him from or otherwise
limiting the following activities: (i) acting as a futures commission merchant, introducing broker,
commodity trading advisor, commodity pool operator, floor broker, leverage transaction merchant,
associated person of any of the foregoing, or as an investment advisor, underwriter, broker or
dealer in securities, or as an affiliated person, director of any investment company, or engaging
in or continuing any conduct or practice in connection with such activity; (ii) engaging in any
type of business practice; (iii) engaging in any activity in connection with the purchase or sale
of any security or commodity or in connection with any violation of federal or state securities
laws or federal commodity laws; (4) were the subject of any order, judgment or decree, not
subsequently reversed, suspended or vacated, of any federal or state authority barring, suspending
or otherwise limiting for more than 60 days the right of such person to engage in any activity
described above under this Item, or to be associated with persons engaged in any such activity; (5)
were found by a court of competent jurisdiction in a civil action or by the Securities and Exchange
Commission to have violated any federal or state securities law and the judgment in subsequently
reversed, suspended or vacate; or (6) were found by a court of competent jurisdiction in a civil
action or by the Commodity Futures Trading Commission to have violated any federal commodities law,
and the judgment in such civil action or finding by the Commodity Futures Trading Commission has
not been subsequently reversed, suspended or vacated.
CHANGE OF CONTROL
On July 24, 2008, the Company completed the Acquisition. Pursuant to a Capital Contribution
Agreement (the Capital Contribution Agreement) executed in connection with the Acquisition, Jim
Glavas, who previously controlled the Company pursuant to his ownership of 21,670,000 shares, or
62.15%, of the Companys Common Stock, now beneficially owns 300,000 shares, or 0.55%, of the
Companys Common Stock and no longer controls the Company. There are no agreements among the
PureRay Shareholders with respect to control of the Company and the PureRay Shareholders are not
acting as group for such purpose. As such, immediately after the
Acquisition, no individual shareholder or shareholder group controlled the Company. For
information about the Acquisition and the Capital Contribution Agreement, please see the
information set forth under Items 1.01 and 2.01 of the PureRay Acquisition Form 8-K, which
information is incorporated herein by reference.
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS
Compensation Discussion and Analysis
Philosophy and Objectives of Our Compensation Program
Our approach to executive compensation is influenced by our belief in attracting and retaining
qualified executive officers. We believe that the ability to attract and retain qualified executive
officers and other key employees is essential to our long term success as we work towards
production of our proprietary multiplexing light bulbs and light bulb charging stations (the
PureRay Technology).
Our plan to attract and retain highly skilled employees is to provide market competitive salaries.
Our compensation program does not currently include any stock, option or other equity or non-equity
incentive award plan. As we further develop the PureRay Technology, we may in the future modify our
plan to better link individual employee objectives with overall company strategies and results, and
to reward executive officers and significant employees for their individual contributions to those
strategies and results.
As of the date of this Information Statement, our named executive officers are Jefrey M. Wallace,
our Chief Executive Officer, President and Secretary; Derek Blackburn, our Chief Financial Officer
and Treasurer; and Jim Glavas, our former President, Chief Executive Officer, Chief Financial
Officer, Secretary, Treasurer and Principal Accounting Officer.
Administration of Our Compensation Program
We currently do not have a standing compensation committee, and our Board in its entirety has
responsibility for establishing, monitoring and implementing our compensation program. Our Board
reviews the compensation of our named executive officers at least on an annual basis to ensure that
compensation levels and benefits are reasonable in light of our corporate performance and continue
to achieve the philosophy and objectives of our compensation program described above.
The primary element of our executive compensation program is base salary, although we may in the
future provide other types of incentive compensation, including bonuses and equity awards. In
general, base salaries for our named executive officers are determined by evaluating the
responsibilities of the executives position, the executives experience and the competitive
marketplace. As appropriate, base salary adjustments will be considered and would take into account
changes in the executives responsibilities, the executives performance and changes in the
competitive marketplace.
The base salaries for Jefrey M. Wallace, our Chief Executive Officer, President and Secretary, and
Derek Blackburn, our Chief Financial Officer and Treasurer, were established based upon
recommendations from our Chief Executive Officer, which recommendations were ratified and confirmed
by our entire
Board. We believe that the base salaries of our named executive officers are appropriate within
the context of the compensation elements provided to such executives and because they are at a
level which remains competitive in the marketplace.
The following sets forth information with respect to compensation paid by us to our directors, our
former chief executive officer and our two most highly compensated executive officers other than
our former chief executive officer, who we refer to as our named executive officers, during the two
most recent fiscal years.
Executive Compensation
We have not paid any salaries to our named executive officers during the fiscal years ended April
30, 2006, April 30, 2007 or April 30, 2008. We have no employment agreements with any of our named
executive officers.
Effective June 1, 2008, the Company agreed to reimburse (the Administrative Services Arrangement)
Kairos for the Companys allocable cost of office facilities, equal to $1,500 per month, and other
overhead and expenses. Pursuant to the Administrative Services Arrangement, the Company also agreed
to reimburse Kairos for the allocable portion of Jefrey M. Wallaces salary for his services as
Chief Executive Officer, President and Secretary of the Company and Chief Executive Officer of
PureRay. Mr. Wallace currently receives a salary of $20,000 per month plus an automobile allowance
of $1,500 per month for his services on behalf of the Company and PureRay, which amounts are
reimbursed by the Company to Kairos in accordance with the Administrative Services Arrangement. Mr.
Wallace receives no compensation for his services as a director of the Company.
Effective May 1, 2008, the Company agreed to pay (the Blackburn Arrangement) Derek Blackburn, the
Chief Financial Officer, Treasurer and a director of the Company, $12,500 per month for his
services as Chief Financial Officer and Treasurer of the Company, and as an employee of the Company
and PureRay, in which capacity Mr. Blackburn is primarily responsible for leading the marketing and
sales efforts for the PureRay Technology. Pursuant to the Blackburn Arrangement, Mr. Blackburn is
also reimbursed for certain travel and other expenses. Mr. Blackburn will receive no compensation
for his services as a director of the Company. Under the Blackburn Arrangement, $12,500 of Mr.
Blackburns compensation was paid directly by PureRay using funds advanced by the Company to
PureRay prior to the Acquisition.
On September 15, 2008, the Companys Board ratified and confirmed each of the Administrative
Services Arrangement and the Blackburn Arrangement. As the Administrative Services Arrangement
and the Blackburn Arrangement do not represent written agreements, each of these arrangements is
terminable by either party without notice. The Company expects to negotiate and enter into final
written agreements memorializing the Administrative Services Arrangement and the Blackburn
Arrangement during the current fiscal year.
The Exchangeable Shares held by our named executive officers increase in value as the shares of our
Common Stock increase in value. As such, our named executive officers will benefit from the
increase in value of our Common Stock.
Compensation of Directors
No compensation was paid to our directors during the fiscal year ended April 30, 2008. There are no
standard arrangements pursuant to which our directors are compensated for services provided as
director.
Effective May 1, 2008, the Company agreed to pay (the Joasil Arrangement) Mickael Joasil, a
director of the Company, $12,500 per month for his services as an employee of the Company and
PureRay, in which capacity Mr. Joasil is primarily responsible for continued research and
development of the PureRay Technology and continued product innovation. Pursuant to the Joasil
Arrangement, Mr. Joasil is also reimbursed for certain travel and other expenses. Mr. Joasil will
receive no compensation for his services as a director of the Company. Under the Joasil
Arrangement, $12,500 of Mr. Joasils compensation was paid directly by PureRay using funds advanced
by the Company to PureRay prior to the Acquisition.
On September 15, 2008, the Companys Board ratified and confirmed the Joasil Arrangement. As the
above arrangement does not represent a written agreement, the foregoing arrangement is terminable
by either party without notice. The Company expects to negotiate and enter into a final written
agreement memorializing the Joasil Arrangement during the current fiscal year.
The Exchangeable Shares held by our directors increase in value as the shares of our Common Stock
increase in value. As such, our directors will benefit from the increase in value of our Common
Stock.
Indemnification
Pursuant to our Articles of Incorporation and Bylaws, we may indemnify an officer or director who
is made a party to any proceeding, including a law suit, because of his position, if he acted in
good faith and in a manner he reasonably believed to be in our best interest. In certain cases, we
may advance expenses incurred in defending any such proceeding. To the extent that the officer or
director is successful on the merits in any such proceeding as to which such person is to be
indemnified, we must indemnify him against all expenses incurred, including attorneys fees. With
respect to a derivative action, indemnity may be made only for expenses actually and reasonably
incurred in defending the proceeding, and if the officer or director is judged liable, only by a
court order. The indemnification is intended to be to the fullest extent permitted by the laws of
the State of Washington.
Regarding indemnification for liabilities arising under the Securities Act of 1933, as amended (the
Securities Act), which may be permitted to directors or officers pursuant to the foregoing
provisions, we are informed that, in the opinion of the Securities and Exchange Commission, such
indemnification is against public policy, as expressed in the Securities Act and is, therefore,
unenforceable.
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
Messrs. ODea (as trustee of the ODea Family Trust), Joasil and Blackburn and Kairos were parties
to the Share Purchase Agreement in their capacities as PureRay Shareholders. Pursuant to the Share
Purchase Agreement, Messrs. ODea (as trustee of the ODea Family Trust), Joasil and Blackburn and
Kairos acquired a beneficial interest in 1,000,000, 12,835,000, 12,835,000 and 5,355,000
Exchangeable Shares, respectively, and 250,000, 3,208,750, 3,208,750 and 1,338,750 shares of our
Special Voting Stock, respectively. Jefrey M. Wallace, a director nominee and our Chief Executive
Officer, President and Secretary, may be deemed to have beneficial ownership of the Exchangeable
Shares, Special Voting Stock and shares of our Common Stock beneficially owned by Kairos pursuant
to his 28% membership interest in Kairos. Mr. Wallace is also a managing member of Kairos. For
information about the Share Purchase Agreement, the Exchangeable Shares and the Special Voting
Stock, please see the information set forth above under Item 1.01 of this Current Report on Form
8-K, which information is incorporated herein by reference.
Kairos was a party to the Escrow Agreement, whereby 4,355,000 of the Exchangeable Shares held by
Kairos have been placed into escrow and will be incrementally released upon the occurrence of
certain performance benchmarks achieved by PureRay. Kairos has appointed the Secretary of PureRay
Acquisition to exercise the limited voting rights attaching to the Exchangeable Shares and Voting
Rights of the Special Voting Stock issued with respect to the Exchangeable Shares held in escrow
until such shares are released. Kairos has no right to dividends or other distributions or payments
made on the Exchangeable Shares held in escrow until such shares are released. Jefrey M. Wallace, a
director nominee and our Chief Executive Officer, President and Secretary, may be deemed to have
beneficial ownership of the Exchangeable Shares, Special Voting Stock and shares of our Common
Stock beneficially owned by Kairos pursuant to his 28% membership interest in Kairos. Mr. Wallace
is also a managing member of Kairos. For information about the Escrow Agreement, please see the
information set forth above in Item 1.01, which is incorporated herein by reference.
Effective January 2008, the Company agreed to pay Kairos certain fees and reimburse Kairos for
certain expenses it incurred in connection with the Acquisition (the Kairos Pre-Acquisition
Arrangement). The
Company paid $79,314 to Kairos pursuant to the Kairos Pre-Acquisition Arrangement, which amount was
paid directly by PureRay using funds advanced by the Company to PureRay prior to the Acquisition.
Jefrey M. Wallace, a director and the Chief Executive Officer of the Company, holds an approximate
28% membership interest in and is a managing member of Kairos.
On September 15, 2008, the Companys Board ratified and confirmed the Kairos Pre-Acquisition
Arrangement.
Our former President advanced a total of $49,500 to the Company for general working capital (the
Loan). For the fiscal 2007 and 2008, the largest aggregate amount of principal outstanding under
the Loan was $29,500 and $49,500, respectively. The Loan is non-interest bearing, unsecured and due
on demand. To date, the Company has not paid any amounts of principal under the Loan.
Other than as set forth above, none of our directors, executive officers or nominees for election
as a director, and no owner of five percent or more of our outstanding shares of Common Stock or
any member of their immediate family have entered into or proposed any transaction in which the
amount involved exceeds $120,000 or one percent of the average of our total assets at our year end
for the last two completed fiscal years.
BOARD COMPOSITION AND COMMITTEES
Our board of directors is currently composed of one member, Jim Glavas. In connection with the
Acquisition, on July 24, 2008, Mr. Glavas submitted his resignation from the board of directors.
Also in connection with the Acquisition, on July 24, 2008, prior to his resignation, Jim Glavas
appointed Derek Blackburn, Mickael Joasil, Frank O Dea and Jefrey M. Wallace as director nominees.
The resignation of Mr. Glavas as a director and the appointment of our director nominees are
effective on the 10th day after the mailing of this Information Statement to our stockholders,
after which our board of directors will be composed of Mr. Blackburn, Mr. Joasil, Mr. ODea and Mr.
Wallace. The director nominees will serve until the close of our 2008 annual meeting of
shareholders or the earlier of their respective resignations or until their respective successors
are elected or appointed and qualified. The Company held no meetings of the Board during fiscal
year 2008.
We currently do not have standing audit, nominating or compensation committees as the Board
believes that it is premature at this stage of the Companys business development to form an audit,
compensation or nominating committee. Currently, our entire Board is responsible for the functions
that would otherwise be handled by these committees. We intend, however, to establish an audit
committee, a nominating committee and a compensation committee of the board of directors.
The Board does not have any defined policy or procedural requirements for shareholders to submit
recommendations or nominations for directors. The Board does not believe that a defined policy with
regard to the consideration of candidates recommended by stockholders is necessary at this time
because, given the early stages of the Companys development, a specific nominating policy would be
premature and of little assistance to the Companys business operations.
The Board has determined that it does not have an audit committee financial expert as defined in
Item 407(d)(5) of Regulation S-K. We do not have an audit committee financial expert because we
believe the cost related to retaining a financial expert at this time is prohibitive. Further,
because of our limited operations, we believe the services of a financial expert are not warranted
at this time.
The Board does not currently provide a process for shareholders to send communications to the Board
because the Board believes that at this point it is premature to develop such processes given the
limited liquidity of the Companys Common Stock. However, the new Board of the Company may in the
future establish a process for shareholder communications.
COMPLIANCE WITH SECTION 16(A) OF THE EXCHANGE ACT
Section 16(a) of the Securities Exchange Act of 1934 requires the Companys directors and executive
officers and persons who own more than ten percent of a registered class of the Companys equity
securities to file with the Securities and Exchange Commission initial reports of ownership and
reports of changes in ownership of Common Stock and other equity securities of the Company.
Officers, directors and greater than ten percent stockholders are required by Securities and
Exchange Commission regulations to furnish the Company with copies of all Section 16(a) forms they
file. To the Companys knowledge, none of the officers, directors or stockholders of the Company
was delinquent in any necessary filings under Section 16(a).
SIGNATURES
In accordance with Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has
caused this Information Statement to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
|
|
|
|
|
PURERAY CORPORATION
|
|
Date: October 9, 2008
|
By:
|
/s/ Jefrey M. Wallace
|
|
|
|
Jefrey M. Wallace
|
|
|
|
Chief Executive Officer
|
|
|
PureRay (CE) (USOTC:PURY)
Historical Stock Chart
From Oct 2024 to Nov 2024
PureRay (CE) (USOTC:PURY)
Historical Stock Chart
From Nov 2023 to Nov 2024